NO20025114L - Trombopoitein-reseptormodulerende peptid - Google Patents

Trombopoitein-reseptormodulerende peptid

Info

Publication number
NO20025114L
NO20025114L NO20025114A NO20025114A NO20025114L NO 20025114 L NO20025114 L NO 20025114L NO 20025114 A NO20025114 A NO 20025114A NO 20025114 A NO20025114 A NO 20025114A NO 20025114 L NO20025114 L NO 20025114L
Authority
NO
Norway
Prior art keywords
receptor modulating
thrombopoietin receptor
modulating peptide
peptide
thrombopoietin
Prior art date
Application number
NO20025114A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025114D0 (no
Inventor
Tatjana Naranda
Lennart Olsson
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of NO20025114D0 publication Critical patent/NO20025114D0/no
Publication of NO20025114L publication Critical patent/NO20025114L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20025114A 2000-04-25 2002-10-24 Trombopoitein-reseptormodulerende peptid NO20025114L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108075A EP1149906A1 (en) 2000-04-25 2000-04-25 Thrombopoietin receptor modulating peptide
PCT/EP2001/004553 WO2001080873A2 (en) 2000-04-25 2001-04-23 Thrombopoietin receptor modulating peptide

Publications (2)

Publication Number Publication Date
NO20025114D0 NO20025114D0 (no) 2002-10-24
NO20025114L true NO20025114L (no) 2002-12-18

Family

ID=8168467

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025114A NO20025114L (no) 2000-04-25 2002-10-24 Trombopoitein-reseptormodulerende peptid

Country Status (24)

Country Link
US (1) US20030181659A1 (pl)
EP (2) EP1149906A1 (pl)
JP (1) JP2003530867A (pl)
KR (1) KR20030009450A (pl)
CN (1) CN1426467A (pl)
AR (1) AR030278A1 (pl)
AU (2) AU6736601A (pl)
BG (1) BG107214A (pl)
BR (1) BR0110383A (pl)
CA (1) CA2407167A1 (pl)
CZ (1) CZ20023517A3 (pl)
EA (1) EA006423B1 (pl)
EE (1) EE200200610A (pl)
GE (1) GEP20063763B (pl)
HU (1) HUP0300559A3 (pl)
IL (1) IL152204A0 (pl)
IS (1) IS6582A (pl)
MX (1) MXPA02010458A (pl)
NO (1) NO20025114L (pl)
PL (1) PL358304A1 (pl)
SK (1) SK15262002A3 (pl)
WO (1) WO2001080873A2 (pl)
YU (1) YU79202A (pl)
ZA (1) ZA200208662B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002359362A1 (en) * 2001-11-07 2003-05-19 Millennium Pharmaceuticals, Inc. Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
KR20050093759A (ko) * 2002-09-18 2005-09-23 오르토-맥네일 파마슈티칼, 인코퍼레이티드 혈소판 및 조혈 줄기세포의 생산을 증가시키는 방법
CN1739017B (zh) 2002-12-11 2011-04-06 弗罗桑医疗设备公司 用作拭子的基于明胶的材料
WO2004100997A2 (en) * 2003-05-12 2004-11-25 Affymax, Inc. Spacer moiety for poly(ethylene glycol) -modified peptides
JP2007530440A (ja) * 2003-05-12 2007-11-01 アフィーマックス・インコーポレイテッド 新規ポリ（エチレングリコール）修飾化合物およびその用途
JP2005187435A (ja) * 2003-12-26 2005-07-14 Otsuka Chemical Co Ltd 血小板産生促進組成物
WO2005072700A2 (en) 2004-01-30 2005-08-11 Ferrosan A/S Haemostatic sprays and compositions
AU2005262070B2 (en) 2004-07-09 2011-01-27 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
CA2641189A1 (en) * 2006-01-31 2007-08-09 Mitsubishi Kagaku Iatron, Inc. Method for determination of condition of disseminated intravascular coagulation syndrome
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
EP2708597B1 (en) * 2011-05-13 2017-11-15 The University of Tokyo Polynucleated megakaryocytic cell and method for manufacturing platelets
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
AU2015333206B2 (en) 2014-10-13 2019-07-11 Ferrosan Medical Devices A/S. Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
CN107771093B (zh) 2015-07-03 2021-06-15 弗罗桑医疗设备公司 用于混合两种组分和用于在存储条件下保持真空的注射器
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
WO2026005476A1 (ko) * 2024-06-26 2026-01-02 주식회사 넥스세라 혈소판 감소증 치료를 위한 재조합 단백질 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498599A (en) * 1994-01-21 1996-03-12 Amgen Inc. Methods for stimulating platelet production
WO1996040189A1 (en) * 1995-06-07 1996-12-19 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6342220B1 (en) * 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
JP2002508160A (ja) * 1998-02-24 2002-03-19 レセプトロン，インコーポレイティド 受容体活性のモジュレーターとしての受容体由来ペプチド

Also Published As

Publication number Publication date
HUP0300559A3 (en) 2005-09-28
WO2001080873A3 (en) 2002-01-31
AR030278A1 (es) 2003-08-20
AU6736601A (en) 2001-11-07
JP2003530867A (ja) 2003-10-21
CN1426467A (zh) 2003-06-25
KR20030009450A (ko) 2003-01-29
GEP20063763B (en) 2006-03-10
SK15262002A3 (sk) 2003-05-02
EP1149906A1 (en) 2001-10-31
CZ20023517A3 (cs) 2003-10-15
WO2001080873A2 (en) 2001-11-01
US20030181659A1 (en) 2003-09-25
EA006423B1 (ru) 2005-12-29
BG107214A (bg) 2003-11-28
IL152204A0 (en) 2003-05-29
EP1278849A2 (en) 2003-01-29
ZA200208662B (en) 2003-10-27
BR0110383A (pt) 2003-01-21
AU2001267366B2 (en) 2005-06-30
IS6582A (is) 2002-10-14
MXPA02010458A (es) 2003-06-06
EA200201138A1 (ru) 2003-06-26
YU79202A (sh) 2006-01-16
CA2407167A1 (en) 2001-11-01
PL358304A1 (pl) 2004-08-09
AU2001267366B9 (en) 2005-07-14
HUP0300559A2 (hu) 2003-06-28
EE200200610A (et) 2004-08-16
NO20025114D0 (no) 2002-10-24

Similar Documents

Publication Publication Date Title
NO20025114D0 (no) Trombopoitein reseptor-modulerende peptid
EP1401476A4 (en) IGF-ANTAGONISTS PEPTIDES
DE50112149D1 (de) MRAM-Anordnung
NO20071303L (no) Farmasoytiske preparater
DE60113887D1 (de) Projektor
ATE252915T1 (de) Formulierung zur verzögerten freisetzung von peptiden
DE50115474D1 (de) Piezoelektrisch erregbares schwingelement
DE60122873D1 (de) Therapeutische porenbildende peptide
EP1311239A4 (en) ORAL PEPTIDE ADMINISTRATION
DE50112432D1 (de) MRAM-Anordnung
DE60334194D1 (de) Transmembranes nfat-hemmendes peptid
NO20025817D0 (no) Oligopeptider
DE50009946D1 (de) Schädlingsbekämpfungsmittel/depsipeptide
DE60112167D1 (de) Vibrator
DE60138276D1 (de) Projektor
DE60131849D1 (de) Sprühvorrichtung
FR2791348B1 (fr) POLYPEPTIDE Npt2B
NO20032963L (no) Peptidforbindelser
EP1181031A4 (en) NOVEL ANTIANGIOGENIC PEPTIDES
EP1159288A4 (en) ALPHA-CONOTOXIN PEPTIDES
EP1359930A4 (en) NOVISPIRINS: ANTIMICROBIAL PEPTIDES
EP1246834A4 (en) EPIDIDYMAL ANTIMICROBIAL PEPTIDES
FI20002159L (fi) Uudet peptidiligandit
DE50015362D1 (de) Winkelschleifer
DE50012174D1 (de) Winkelschleifer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application